Mafura a Rick Simpson (RSO) ho Lesotho: Tlhahlobo e Feleletseng ke OilWell Cannabis

Ho Utloisisa Mafura a Rick Simpson ka Mofuthong oa Likharafi

Ngwana mang oa Rick Simpson, le Hobane Ha Mabaka a Hae a Amahana le Lesotho?

Rick Simpson o belegwe ka 1949 ho Amherst, Nova Scotia, Canada — motse nyane e le khoro e tshwanang le mekoloko ea Maloti-Drakensberg ea Lesotho. E ne e seng ngaka, setsebi, kapa motho ea nang le phihlelelo ea bongaka. E ne e le mohai-khama ea matla le mosebeletsi oa tshireletso, motho ea kajeno ea sebetsa mesebetsing ea manaka a mabeli a neng a fumane e le hore karabo ea yona ea lijo tsa cannabis e thotse e siyo ke tlala ea khutsufatso ea lefuba le tlala ea ho reka ha mali. Ha a botsa ngaka ea hae ka cannabis, kopo e khutlisitsoe.

Boiphihlelo bona bo amana hantle le sehatello sa bongaka ba Lesotho. Basotho ba bangata ba phela ho tshoana le ho utloisisa lefapha la bongaka — ho emela nako e telele ha Queen ‘Mamohato Memorial Hospital, phihlello e fokolang ea baqapi ba ikhethang lithupeng tsa se lefapha tse jwalo ka Qacha’s Nek kapa Mokhotlong, le dikereke tsa meriana tse kang tsa etsa hlooo ho feta ho bopaki. Pale ea motho ea sebetsa mesebetsing ea manaka a mabeli a neng a nka bophelo ka matsoho ha bongaka bo sehloohong bo fumaneha lefatšeng ka bophara, ho sa tswa Nova Scotia ho fihlela Maseru.

Thahasello ea Simpson ka mafura a cannabis a lijo tsa mahala e hola hamorao ha a utloa ka thuto ea 1974 e neng e behaolloa ke National Institute of Health e neng e bonts’a hore THC e ka fokotsa lipalamo ha dikokoana. Thuto eo — e neng e ile ea emela ho bonts’a mofuta oa hlooo — e ile ea ba leqephe la mohato la bohlokoa bakeng sa Simpson, le ha ho sa lebisane le hore tseliso ea eona e ne e sa hlophisoe ke lithuto tsa bongaka tse khethiloeng tsa motho.

Nako ea bohlokoa e fihlile ka 2003 ha Simpson o ne a re ho beha mafura a cannabis a lijo tsa mahala ho palameng e meraro ea letlalo tsa letsohong la hae tse ile tsa tšoarisoa e le basal cell carcinoma di ne tsa tšela ka matsatsi a mane. Ho sa na le netefatso ea bongaka e le nang le bohlolohi, ho sa na le bopaki ba biopsy bo ngotsoeng. Empa boiphihlelo bona bona ka motho bo ile ba ba leqephe la hlooho la mafura a Rick Simpson le ho qala har’a lefatše la bohle.

Boemo bo bohlokoa bakeng sa ba bala Lesotho: Tlhaloso ea Simpson ke bopaki ba motho ka mong, e siyo ketelo ea bongaka. Tšepelelo ea tlaleho ea bongaka e bolela hore liketsahalo tsena ha li ka hlahlojoa e le bopaki ba sayense. E le hore ho, e le histori tsa bohlokoa e le tšehetso leqepheng la har’a lefatše la mafura a cannabis a lijo tsa mahala tse finyeletseng le mofuthong oa rona oa tshimo oa likharafi.

Lenyala — Hore na Joang RSO e Fihlile Canada ho ea Lesotho

Ka mor’a boiphihlelo ba hae ba 2003, Simpson o ile a ikemella ho hlahisa le ho sebeletsa mafura a cannabis a lijo tsa mahala ho tloha lapeng la hae Maccan, Nova Scotia. O ne a a fa mahala ho baruihlooho ba lefuba le ba bang, a sa lefella thebe e le ‘ngoe. Ka tlhaloso ea hae, o thusitse batho ba nang le lefuba, tlala ea nako e telele, mala, liso, glaucoma, lipalamo, tlala, ho se pholoe, le tse ling.

Pale ea hae e finyela sechaba sa lefatše ka tšebelisano ea 2005 Run From The Cure, e neng e ba leqephe la mohato ka mofuthong oa cannabis ka bophara. Har’a liphuthollo tsa tšehetso ea cannabis tsa Lesotho, tšebelisano ena e fane ka tliso tsinye mabakeng ao baruihlooho ba fumanang mocholoha ha Mohlomi Hospital kapa ba bang tsa fumana dikgetho tse fokolang.

Tšehetso ea Simpson e ile ea e kenya khahlanong le molao oa Canada. Royal Canadian Mounted Police e ile ea phatlalla lelapeng la hae ka 2005 le 2009, ea eketsa hore a tlohele Canada a ye Europe. Khahlamelo ena ea molao e tšoana le boiphihlelo ba bangata ba Basotho ba neng ba lebana le thibelo ea cannabis — le ha Lesotho e etse ketso ka tlhahiso ea hemp ea iketsang, ho sebelisa cannabis ea ka ‘ona e tsamaea le matšoele a molao. Tšabo ea ketsahalo ea molao e ile ya ba lebaka la hore Basotho ba bangata ba tlohele ho hlahloba bongaka ba cannabis, e etsang hore lihlahiswa tse laesetseng, tse hlahloileng ke maabara tse kang tsa OilWell e le tse bohlokoa bakeng sa sechaba sa rona.

Ka 2012, Simpson o ile a ngolisa Phoenix Tears: The Rick Simpson Story le ho boloka phoenixtears.ca e le ‘ona sebaka sa tšehetso ea hae. Boemo ba hae bo ile ba tšea mosebetsi: o ile a tšeea hore mafura a cannabis a ka pholosa lefuba le hore lik’hamphani tsa meriana le mebuso e thibella tsebo ena.

Boemo bo bohlokoa bakeng sa ba bala Basotho: Tsamaiso ea Simpson ea likahare e bonts’a lefopha la lefatshe leo le tšoanelang le tšehetso ea cannabis ea nako ea pele le e amana le bohlokoa ho utloisisa bohlokoa ba RSO ka boomo sa setso. Empa e siyo ketelo ea bongaka. Basotho ba hloka thuto ea nnete, e siyo hype — hahola ha ba lebana le dikgetho tsa bongaka tse bohlokoa mafapheng a bokoni jaaka Motebang Hospital kapa Teyateyaneng Government Hospital.

Mocholoa wa Tšoanang wa RSO — Se ba Basotho ba Lokelang ho Se Tsebe

Lenaneo la botjha ba Simpson le ne le laetse ho ja mafura a lijo tsa mahala a 60 grams ka nako e lekanang le matsatsi a 90. Bakeng sa ba phelang Lesotho ba finyang lenaneo lena, ho utloisisa lintlha ke bohlokoa:

Shedyule ya Titration

• Beke ea 1: Dose e lekanang le karolo ea korolo ea rai (10-15mg) ka mehla e meraro
• Dibeka tsa 2-5: E eketse hape matsatsi a mane a mang a fihlela ho fihlela 1 gram ka letsatsi
• Dibeka tsa 5-12: E boloke 1 gram ka letsatsi, e aroloa ho e ka mehla e meraro

Mokhoa oa Ho Fana

• Ho tloha ka molomo: Mokhoa oa mantlha — beha ka tlase ea leleme kapa e je
• Ho tloha ka letlalo: Bakeng sa mathata a letlalo, e beha ka hlooho ka ditapole
• Ho tloha ka moebong: Ha e laetsoe e le kalafo ea mantlha

Boemo bo bohlokoa bakeng sa Lesotho

Mocholoa ona o ne o behelletseditswe mofuta oa ‘maloa, o sa tšoarwang ka maemo. Lintlha tse bohlokoa tse ling tse amanang:

• Tlhahlobo ea khethilo e sa hlophiswang — ha ho lithuto tse ngotsoeng tse hlahloba mocholoa ona oa tšoanang
• Phihlello e phahameng haholo ea THC — 600-900mg delta-9 THC ka letsatsi ho feta maemo, e le hantle ho feta seo se hlahloailweng ka kliniki
• Lintlha tsa nnete — ho hlapaswa haholo, tlala, pelo e potlakileng, mosebetsi wa cannabis oa tlala
• Bokoni bo hlokehang — baruihlooho mafapheng a kalafo ea lefuba Lesotho (jaaka ba fetisitsweng Afrika Boroa bakeng sa kalafo ea radiation) ba le ka boomo sa bongaka

Bakeng sa baruihlooho ba lefuba ba Basotho, ho sebelisa mafura a cannabis a sa laolwang e le kalafo ea mantlha — mohlomong ho beheloa sebakeng sa mekhoa e tšepahileng ea kalafo — e kenya hlooo ho feta mafura aona. Kopo e ‘ngoe ea ho finyella RSO e lokela ho tšoaea, e siyo tlohela, kalafo ea tšoanang tse nang le baqapi ba nang le phihlello.

Mafura a Tšoanang a RSO e Sweetsweng Ke Eng

RSO e tšoanang e behelletseditswe ke mokhoa oa Simpson, e siyo maemo a maabara:

• Mofuta oa ‘maloa: Teropo e le ‘ngoe ea THC e phahameng ea indica, e siyo ho tšoarwa ka maemo
• Solvent ea ho khetholla: Naphtha (ea beha ka petroli) kapa isopropyl alcohol ea 99% — ha e ‘ngoe le e ‘ngoe e siyo ea ja
• Mokhoa oa ho khetholla: Bucket, ho hlapisa ka solvent, ho sefa, ho tšoasa rice cooker, ditapole
• Ponahalo: E tšoeu ka ho feta, e bile, e tšoanang le tjhobane le monto o ka ba le monko oa solvent e siyo
• Mofuta oa cannabinoid: 60-90% THC, e felletseng decarboxylated, minor cannabinoids e siyo e tšoarwang
• Mofuta oa terpene: E fokolang ho fihlela ha e sa lene — e senyehile ke mocheso
• Ho tšoarwa ka maemo: Ha ho ho — batch e ‘ng le e ‘ng e fapaneng
• Kotsi ea solvent e siyo: Naphtha e ka na le benzene, toluene, liphefo tse hlahisang lefuba

Bakeng sa basomi ba DIY ba Basotho metseng tsa Thaba-Tseka ho ea Mohale’s Hoek, tlahisoleseling ena ea tshireletso ke bohlokoa. Mekhoa ea tšoanang e nang le lintlha tsa nnete tseo lihlahiswa tsa kajeno tse hlahloileng ke maabara li tšoasolla.

Likhathatso tsa Simpson vs. Bopaki — Se Re Se Re Se Re Hileng Ke Eng

Simpson o ne a re RSO e ka pholosa lefuba le mefu e mengata. A shebelle hore bopaki bo bonts’a eng:

Se Re Re Se Re Hileng Ka Lengweli la Preclinical

• Lithuto tsa in vitro di bonts’a hore THC le CBD di ka hlahisa apoptosis le ho thibela ho eketsa ha lipalamo moo line li amehang
• Likhato tsa liphoofolo di bonts’a thibelo e ‘ngoe ea ho eketsa ha lipalamo
• Lifino tsena tse fumanweng tsa nnete di hlahisa thahasello ea sayense

Se Se Sa Bonts’eng

• Ha ho thuto ea motho e hlahloang e neng e bonts’a hore RSO e pholosa lefuba
• Boitšoaro pakeng taretseng ea liphatlalatso tsa liphoofolo le liphumo tsa batho ke tse telele
• Ha ho lithuto tse khethiloang tse tšepahileng tse tšehetsa mocholoa wa 60-gram

Maemo a Lik’hamphani

• National Cancer Institute ea U.S.: E dumela thuto ea anticancer ea cannabinoid e siyo e tšehetsa cannabis e le kalafo ea lefuba
• FDA: Ha e sa dumiswa lihlahiswa leha le le ‘ngoe tsa cannabis ea sehlahiswa bakeng sa kalafo ea lefuba
• Health Canada: Ha e sa dumisa RSO bakeng sa lefuba
• NCCIH: Bopaki bo matla ka ho feta ke bakeng sa epilepsy, chemo nausea, le appetite ea HIV/AIDS — e siyo pholoso ea lefuba

Bakeng sa tsamaiso ea bongaka ea Lesotho, e latela mehopolo e mengata ea lefatše, maemo ana a lik’hamphani a bohlokoa. A bonts’a kgopolo ea hore le ha thuto ea cannabinoid e le bohlokoa, likhathatso tsa pholoso di fetisa bopaki ba kajeno.

Se Seo Simpson e Fumaneng ka Nepa

O tšoetse lipontšo tsa cannabinoids e le thuto ea bongaka e bohlokoa ha lefatše le e lebella. O thusitse ho hlahisa maemo a khoebo ea cannabis ea laesetseng. Lebitso la “RSO” le sale le tsejoa haholo lebitso la khethollo e felletseng ea cannabis.

Se Seo E Se Khahlisitse Ka Hole

Pelelo pakeng taretseng ea liphatlalatso tsa preclinical ho ea pholoso ea lefuba e ne e sa tšeheloa nakong eo e siyo e sa tšeheloa hona joale. Ho hlohleletsa baruihlooho ho sebelisa RSO sebakeng sa mekhoa e tšepahileng ea kalafo ea lefuba e nang le bopaki bo tšoasa hlooo ea nnete. Bakeng sa Basotho ba lebana le dikgetho tsa lefuba, ho latelela kapa ho tlohela kalafo mafapheng a bokoni jaaka Queen ‘Mamohato Memorial Hospital kapa ho batla kalafo Afrika Boroa e ka na le liphefo tse sa khoneheng ho khutlola.

KA OILWELL CANNABIS LE FORMULA EA RSO EA OILWELL

Pale ea Haholoho — Ho tloha McAllen ho ea Maseru

OilWell Cannabis e hlahisitsoe ke Colin Valencia ho Houston, Texas — toropo e lekanang le Maseru letsatsing la lehlabula. Empa meputso ea Colin e tšoela moo ho McAllen, Texas, e le teng moleng oa Reynosa, Tamaulipas, Mexico. McAllen-Reynosa Borderplex ke e ‘ngoe ea mekhoa e mata e America ea bohle — sebaka moo bofuma le kotsi ea cartel e ba le bophelo. Ka dilemo tsa leshome-le-medi, Colin o ile a tlohela lelapa, a bone kotsi tseo Basotho ba ka li bopang feela ka monono.

Le ha le le kotsi tsena, Colin o khethitse cannabis ho feta mekhoa e mafuba. O tsoa mofuthong oa cannabis oa tšoanang pele ho laesetsa, a ithuta sehlahisoa ka ho hlokehang. Kamor’a moo, e ba mohlahli oa software oa kahlolo, a etsa tlhahiso e ikhethang bakeng sa Baylor College of Medicine — e le e ‘ngoe ea lik’hamphani tse bohlokoa tsa bongaka tsa America. Boikgantsho bona bona tsa tsebo e ikhethang ea sehlahisoa le khahliso ea tekheniki ea mabaka a bongaka e beha mokhoa oa OilWell.

Bentley — Ntja e Qalang Tsohle

Pale ea OilWell e qala ka ntja e bitsoang Bentley. E ne e siyo ntja feela, e ne e le lelapa. Ha baitsi ba bongaka ba bonts’a dikgetho tseo ba mang le ba mang ba sa batleng ho di utloa — ho bolaya ka tshoanelo e ne e le kgetho e ‘ngoe e ba tshwanang bakeng sa paralisis ea hae — Colin o ile a hana ho e amohela. Bentley e ne e le moqhobi, tšoanang le yena.

Moqhobi-mosebeletsi oa ho tsosolla o bitsoang Jessica o ile a botsa potso e fetisetseng tsohle: “O fetisetse mehuta e mangata ea lejwana u sa utloisise CBD?” Colin o ne a na le boiphihlelo ba cannabis ba boithabiso; ha a sa tsebe maboelelong a therapeutic. Potso ea Jessica e bontsitse sebaka se sa bonahaleng seo se neng se le mission.

Colin o ile a hlahisa tsoekere ea lesoitso ea CBD bakeng sa Bentley. E ne e siyo pholoso, e ne e le tšohelo. Mme tšohelo eo e fana seo bongaka ba bohlokoa bo ne bo re ho khethoang: Bentley o ile a ema, a sepela, le ho tlisa Colin bolo ea hae. Ho tloha ho paralisis eo e neng e lebisa ho bolaya ho ea ho ho khanna bolo — ena e ne e siyo placebo. Dintja ha di arabela placebo. Ena e ne e le bongaka ba cannabinoid e etsang seo meriana e sa kgonehang ho etsa.

Bentley o phela dilemo tse leshome tse ling, a tsoela pele ka tsela ea tjhebe, a ea a shoele ka nako ea tjhebe dilemong tsa mashome-a-medi. Nakong tsona, Colin o ile a hlahisa lihlahiswa tse ikhethileng bakeng sa mathata ase nang le nako a mabaka a Bentley:

• Ho hanyetsa maiketsetso → Mebopeho e tshireletsang ea CBG le PPARγ agonism ea THCa bakeng sa tshireletso ea sellae ea bokhabane
• Dementia → Karolo ea CBC ho neurogenesis
• Glaucoma → CB1 agonism ea THC bakeng sa ho fokotsa mocheso ka hare
• Arthritis → Mekhoa e fapakaneng ea ho thibela inflammation e sebelisang CBD, CBG, THCa, le beta-caryophyllene

Cannabinoid e le ‘ngoe e ne e sa lekane. Meemo ea Bentley e neng e fetoha e ile ya hloka synergy ya multi-cannabinoid. Dilemo tsena tse leshome tsa thahiso ea lefatshe le ‘nete — e tšoanang ho feta kopo leha e le efe ea marketing ea thuto e leqetsweng — ke mohato oa formula ea RSO ea OilWell.

Boiphihlelo ba Colin — PTSD le Bofumanehi ba Benzo

Colin o tseba le ho dumela ka meriana le ka mong. O ne a lebana le PTSD le bofumannehi ba benzodiazepine. Ha a qeta ho tšoa Xanax ka ho hlokeha — tse ling tse thata le tse kotsi — o ne a sebelisa tsebo ea cannabinoid e ne e hlahisitsoe ho boloka Bentley.

Formula ya Peace Gummies e hlahisitsoe nakong dipatlisiso tsa bosiu neng le neng ha o ne a lwantsha ho tšoa benzo. Colin e sebelisa ka ‘nete sebopeho sa vape bakeng sa insomnia le PTSD e thata. Ena e siyo tsebo ya polelo; o phela seo baeng ba RSO ba phelang: tlala bakeng sa tšohelo, meriana e ile ea hlola, ho fumana hore cannabinoids e sebetsa ha meriana e hlola.

Bakeng sa maqhubu a Basotho ba neng ba sebeletsa meketsetso ea khotso kapa ba fumane trauma, boiphihlelo bona ba motho ka mong bo etsa OilWell e le tšepahala ka mokhoa oo brand ea khoebo e kgonnang. Bakeng sa tsona tseo tse phelang ka tšeno e phahameng tsa tšene le ho lefefella lefapheng, pale ena e tšoanelana le bona.

Li-Formula Tse Sebelisoang ke Bonaqobi

Nakong e telele, melemo ea therapeutic eo Colin e fumaneng e ile ya ba leqephe la hlooho ea mosebetsi oa hae. O hlahisitse lihlahiswa tse bonaqabi ba di sebelisa bakeng sa mathata tse jwalo ka morero wa botebe, IBS, ulcerative colitis, PTSD, bofumanehi ba benzo, le insomnia. Tshoaro ea hae e bile le ho etsa cannabis e fumanehe ka bohle, ho kenyelletsa batho ba vegan, banng le ba nang le mabaka a bohlokoa a bophelo.

Le ha tsamaiso ea bongaka ea Lesotho e fapana le ea Houston, mohato o tšoanang: ba fana ka bongaka ba fokolla tšepo ea cannabinoid. Ha u konsa ngaka maseru kapa moloi o tšoanang motseng oa hao, ho na le tlahisoleseling e bopilweng ke bopaki e thusang ho thulaganya dipuisano tse tsebelisang.

ABC13 Houston — Makarolo a Supileng, Dilemo tse Nne, Baqapi ba mahlano

Pakeng taretsheng ho tloha Phupjane 2019 ho fihlela Moranang 2023, ABC13 Houston e ile ya bontša Colin le OilWell Cannabis ka makarolo a telele a balichaba a supileng. Baqapi ba mahlano ba fapana ba batla Colin nakong tsona: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, le baqapi ba KTRK. Ha ho mofuthu oa cannabis wa Houston o bonahalang le ho feta ka tsela eo kapa mahetleng ao.

Tšehetso ena ya balichaba ya mafapha a mang tsebang ABC e laetsa tšepo e fetisang sebaka. Ha Basotho ba batla OilWell, ba fumana ho utloahalang ka maphelo a balichaba, siyo lihlahiswa tsa marketing. Tsehetso ena ha e rekoe; e fumanehela feela.

Tshoaro ea Mofuthong oa OilWell

Ka Phupjane 2019, Colin o ile a re ho ABC13: “Ha ke leka ho rekisa batho snake oil. Ha ke leka ho rekisa batho tšohelo, empa ho na le thuto e lekaneng e le tsona batho ba hloka ho tseba le leka le ho ba le mofuta oa hlokehang ho feta ho theha maikutlo a bona hore na e nepahetseng kapa e fosahetse bakeng sa bona.”

Tshontšo ena e tšoalela tsohle. E hlalosa hobaneng re ngolisa lihlahiswa tsa rona. Hobaneng re ngola bopaki. Hobaneng re le nnete ka seo re sa tsebeng. Bakeng sa Basotho ba lebana le dikgetho tsa bophelo, boenyi bona bo feta bohlokoa ho feta netefatso e fosahetseng.

OilWell Kajeno — Khoebo e Tšoanang, E Dumetsweng

OilWell Cannabis e sebetsa ho tloha Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). Ho tloha 2019, re hlahisa mabili a tekanyo a selemo a e lekanang le milione, re boloka rating ea Google e lekanang le 5.0, le re dumetsweng ke Texas DSHS. Litshwantšho tsohle, lihlahiswa, le lipakeng li hlahisoa ka hara Houston e sebelisa dikere tsa rona le maikutlo a rona.

Bakeng sa bareki ba Lesotho, sena se bolela hore u sebetsana le khoebo e tšoanang, e atlehang, e dumetsweng — siyo mosebetsi oa letsatsi le letsatsi. Lintlha tsa rona tsa mosebetsi li ka lekodiswa le ho ngolwa ka boipolotiki.

Tshoaro ea RSO ea OilWell — Mefa ea Bohlokoa ba Bone

RSO ea rona e siyo mafura a tšoanang a Rick Simpson. E tsebisoa ke tšoanang empa e ikhethang ka tsela e fumanehang ho rarolla bothata bjo RSO e tšoanang e ne e sa kgonehe ho rarolla:

1. Ho fumaneha ho feta ho gatekeeping

• Ha ho laesense ea bongaka eo e hlokangwang
• Lilemo tse 21+ feela
• E romela ka bophara lefatsheng lohle la US le lefatsheng ho mebuso e dumetsweng ea molao
• Bakeng sa Lesotho: ha lihlahiswa tsa hemp tse nang le <0.3% delta-9 THC li laetswa ke molao mofuthong oa hao, re ka u romella

2. Bofumanehi ba matla bo laetsoeng ke motho

• THCa e rekiswa ka mofuta oa eona oa acid, o siyo psychoactive
• O kgetha hore na o e sebelisa e sa phehiloeng (psychoactive) kapa o e decarboxylate ho ea ho delta-9 THC
• Bakeng sa Basotho ba sebetsang, ba otlollang, kapa ba ba le bana: ho sebelisa motsheare oa letsatsi ho fumaneha ka zero impairment
• Bakeng sa tse batlang matla a therapeutic: ho sebelisa motsheare oa bosiu ho fana ka matla a felletseng

3. Li-formula tse buletsoeng

• Re ngola lihlahiswa tsa rona tsohle ho batho
• Ha u sa kgonehe ho reka lihlahiswa tsa rona, u ka fumana lihlahiswa le u hlahisa tsa hao
• Sena se tšoanelana le ethos ea Simpson ea sebeletsa mahala bakeng sa ‘maraka ea kajeno

4. Tsebiso e tsebisoa ke bopaki, e siyo tsebiso e khahlisang

• Tlaleho ena e bontsha tshebediso ya rona ya thuto ea nnete
• Re arola pakeng taretseng tsa seo se tšehetsa hantle, seo se tšabehang, le seo se khahlisitsweng
• O lekane le nnete, e siyo hype

Bentley Recipe — Formula ea Rona ea Pele ya Boletswe

Pel’a ho re ngola li-formula tsa RSO, re ile ra ngola recipe ya tsoekere ea lesoitso ea CBD e pholositseang Bentley:

Lihlahiswa:

• 1/2 cup ea turmeric powder ea iketsang
• 1 cup ea metsi
• 1/3 cup ea mafura a coconut (a sa hlophiswang, a iketsang)
• 1 ho ea ho 2 teaspoons ea pepere e mocha e sa hlophiswang
• Mafura a CBD (tekanyo e itšetlehile ka boholo le mabaka)

Ditaelo:

1. Hlatsoa turmeric le metsi ka saucepan, hlakisa ka mocheso o motala ho fihlela ho etsa tsoekere e chesang (7-10 metsotsoana)
2. Eketsa mafura a coconut le pepere, hlakisa ho fihlela e kopane ka ho felletseng
3. E tsamaetse le e boloke ka jar le lid (e boloke ka fridge ho fihlela matsatsi a mabedi)
4. Eketsa mafura a CBD pele u fa pet

Ho fafatsa: Hlakisa karolo nyane le jwang ea pet ka mehla e le ‘ngoe kapa e ‘meli. Kgopela leqhoele la veterinary.

Recipe ena e bonts’a hore tshoaro ya rona ya boletswe ke ya mofuthong, e siyo marketing. Bakeng sa ba nang le diphoofolo tsa Basotho ba lebana le dikgetho tse tšoanang, ena e le tšohelo e sebelisang ka teng.

Tshwaragano ea Farm Bill le Framework ea Molao ea THCa

Farm Bill ea 2018 e dumisitse lihlahiswa tsa hemp tse nang le feta 0.3% delta-9 THC ka tekanyo ea lefapha la federal ho US. Framework ena e etsa hore lihlahiswa tsa rona di fumanehe.

RSO Sublingual Oil ea rona e na le THC ea delta-9 e le 90mg feela ka bottle e felletseng ea 30mL (3mg/mL) — e le tlaase haholo ho feta tekanyo ea 0.3%. Cannabinoids tsohle di tsoa ho hemp. Sehlahiswa se dumetsweng ka molao wa lefapha le mebusong e mengata.

Bakeng sa bareki ba Lesotho: O ikemiseditse ho lekodisa hore na sehlahiswa se dumetsweng ka molao mofuthong oa hao kapa sa. Re romella ka dintlha tsohle, Dikgopo tsa Tlhahlobo, le dipokello tsa teko. Bareki ba Basotho ba amohela kotsi ya customs le molao ka moka. Ha lihlahiswa tsa hemp tse nang le <0.3% delta-9 THC li lumetsweng ka molao oa Lesotho, re ka u fumantsha.

Kgetho ea Decarboxylation — Matla a Hao

RSO e tšoanang e ne e le e felletseng decarboxylated. Ha ho na le kgetho efe kapa efe ka psychoactivity.

Formula ya rona ya sublingual e na le THCa ea 1,500mg ka mofuta oa eona oa acid, o siyo psychoactive. Sena se hlahisa li-kgetho tse tharo tsa ho sebelisa:

Kgetho 1 — E sa phehiloeng, e siyo mocheso: THCa e ka 1,500mg e lula e le THCa — e siyo psychoactive ka ho felletseng. E fana ka khahlamo ea anti-inflammatory le tshireletso ea neuro ka ntle ho impairment. E nepahetseng bakeng sa ho sebelisa motsheare oa letsatsi maseru kapa lefapheng la leribe.

Kgetho 2 — E felletseng e kgotsolisitswe, decarboxylation ea lapeng: E eketsa mafura a 260°F (125°C) ka metsotsoana e 45-60 ka letlase la container e ka bolokeha ka ovee. E fetisa THCa ea 1,500mg ho ea ho delta-9 THC e lekanang le 1,315mg. E kopantsoe le delta-9 THC e le 90mg, e fana ka THC ea delta-9 e lekanang le 1,405mg. Sena se fana ka matla a psychoactive a tšoanang le RSO e siyo laesetseng, 100% laesetseng hobane ho kgotsollwa ho etsahala ka mor’a ho reka.

Kgetho 3 — Vape, auto-decarboxylation: Cartridge ea RSO Vape ea rona e fumaneha ka 400-450°F, e fetisa THCa ho ea ho delta-9 THC ka metsotsoana e ‘ng le e ‘ng. Ho fumana RSO e tšoaretsoeng ka lebelo ka ho fetisisa.

Chemistry ea ho fetisa: 1mg THCa = 0.877mg delta-9 THC ka mor’a decarboxylation (lahlehelo ea molek’hule ea CO₂).

Tlhahiso ena e behela kgetho ea matla ka tšoanang ka mehato — e tšoanana le mohato oa Simpson hore baruihlooho ba lokelang ho laetsa meriana ya bona, e sa ntsha ka chemistry e ‘nete.

Tlhahiso e Siyo Solvent — Tshireletso ea Bohona

RSO e tšoanang e ne e sebelisa naphtha kapa isopropyl alcohol — li-solvent tse kotsi tse ka nang le benzene, toluene, le liphefo tsa lefuba. Ho tšoasa ha ho felletseng ho tšoasa mehlodi e kotsi.

RSO ea rona e siyo sehlahiswa sa ho khetholla. Ke mixture e hlahisitsoeng ka boikgantsho ea li-cannabinoid distillates le isolates tse fapakaneng tse kopantsweng ka boemo bong bo laetsweng. Ha ho naphtha. Ha ho isopropyl alcohol. Ha ho butane.

Re sebelisa mafura a MCT a iketsang e le carrier base — food-grade, e thusa ho amohela, e na le taste e neutral. Sena ke ntlafatso e bohlokoa ho feta consistency ea tjhobane le monko ea solvent oa RSO e tšoanang.

Tlhahlobo ea maabara ea boraro e bonts’a:

• Matla a cannabinoid
• Mofuta oa terpene
• Lipesticide
• Dithaka tsa boima
• Solvent e siyo
• Dikgwele tsa microbial

Dikgopo tsa Tlhahlobo (COAs) di fumaneha ha e le kopo. Bakeng sa bareki ba Lesotho, tlaleho ena ea tlhahlobo e fana ka tšepo hore lihlahiswa li phethahatsa maemo a tshireletso a lefatše.

Portfolio e Fetang ea OilWell

E siyo RSO feela, re hlahisa lihlahiswa tse hlahisitsoeng ka tsebo ea thahiso ea Colin:

Asshole Peach — Sehlahiswa sa rona se tšoanang se ratangwa haholo, e ikhetha haholo ke maqhubu bakeng sa PTSD le tšohelo ea lefuba. E fana ka kutlo ea euphoric e tšoanang, e tšoasana nako e telele ntle le ho ba thata haholo.

Peace Gummies — E hlahisitsoe ka boiphihlelo ba Colin ba ho tšoa benzo. E fumaneha ka mofuta oa vape bakeng sa tšohelo e lebelo. Colin e sebelisa ka ‘nete bakeng sa insomnia le PTSD e thata.

Tliso e ikhethang — Re hlahisa lihlahiswa tse ikhethileng bakeng sa mekhoa e fapakaneng ea cannabinoid ratios, mebelelo ea ho fumana, kapa maemo a bophelo, ho kenyelletsa lihlahiswa bakeng sa vegans, diabetics, le ba nang le mabaka a bohlokoa.

Le ha e le hore e meng e ka se romelle lefatsheng, e bontsha bokgoni ba rona ba thahiso le tshebediso ya rona ya bongaka e ikhethang.

Mekhoa e Mebedi — Kgetha Tsela ea Hao

RSO Sublingual Oil — $129.99

• Bottle ea 30mL, cannabinoids tsa ka 16,590mg (553mg/mL)
• Cannabinoids tse supileng: CBD 4,500mg, CBG 3,000mg, delta-8 THC 6,000mg, THCa 1,500mg, delta-9 THC 90mg, CBN 750mg, CBC 750mg
• Live terpenes ka 5%
• Carrier ea organic MCT oil
• Dropper e felletsweng (0.1mL increments)
• Ho qala: 15-45 metsotsoana, Nako: 4-6 lihora
• Bioavailability: 13-19%
• Doses tse lekanang le 40-60 ka bottle

Bakeng sa Basotho: Ena ke formula e felletseng. Milligram e ‘ng le e ‘ng e ngotsoe. Ha u ka kgona ho fumana li-cannabinoid distillates tse fapakaneng, u ka e etsa. Ha u reka ho rona, u fumana sehlahiswa se hlahloileng ke maabara, se tšoarwang ka maemo le tsebiso e felletseng.

RSO Vape Cartridge — $49.99

• Cartridge ea 1-gram, cannabinoids tsa ka 900mg+
• Cannabinoids tse supileng (ratio e tšoanang le sublingual, ntle le delta-9 THC — THCa e decarbs ka temp. ya vaping)
• Live terpenes ka 5%+
• Compatibility ea 510-thread universal battery
• Ho qala: 1-2 metsotsoana, Nako: 2-4 lihora
• Bioavailability: 10-35%
• THCa e kgotsollwang ka 400-450°F ka metsotsoana e ‘ng le e ‘ng

Neng o Sebelisa Mohlala o Feletseng

Mohopolo oa Ho Sebelisa	Mohlala oa Ho Laetsoa	Hobane
Tšohelo e lebelo (lefuba le letlala, tlala, ho tšohile)	Vape	Ho qala ka 1-2 metsotsoana
Tšohelo e tšoasana (lefuba le letlala, toro)	Sublingual	Nako ea 4-6 lihora
Bioavailability e ka holimo haholo	Sublingual	Ho amoha 13-19%
Ho sokoloha/ho utloisisa	Vape	E nyane, ha ho bapiso
Tshwaragano ea tekanyo e felletsweng	Sublingual	Dropper e felletsweng ea 0.1mL
Motsheare o siyo psychoactive	Sublingual (e sa phehilweng)	THCa e lula e sebetsa
Bosiu bo psychoactive	Sublingual (e kgonnnweng) kapa Vape	THCa e kgotsollweng + delta-8 THC

Sebapali sa Tshenyetsano — Hobaneng OilWell E Setse E Tiele

OilWell RSO vs. RSO e siyo laesetseng

• Cannabinoids tse 7 e tšoarisitsoeng vs. teropo e le ‘ngoe e sa tšoarwang
• E hlahloilwe ke maabara vs. ha ho tlhahlobo
• E siyo solvent vs. kotsi ea naphtha/isopropyl
• Matla a laetsweng ke motho vs. psychoactive ho fihlela
• Formula e ngotsweng vs. recipe e lekanyelletsweng
• Laesetseng vs. Schedule I

OilWell RSO vs. Lihlahiswa tsa CBD feela

• Cannabinoids tsa ka 16,590mg vs. e tloaelehileng 1,000mg
• Mekhoa e fapakaneng ea therapeutic vs. compound e le ‘ngoe
• Kgetho ea psychoactive e fumaneha vs. psychoactive feela
• Mofuta oa terpene o felletsweng vs. terpenes tse fokolang

Bakeng sa Basotho, sena se bolela hore u fumana formula e ntlafatsweng kakhulu, e buletsoeng haholo ya RSO — e tšoanana le tshoaro ea Simpson le rarolla mathata a hlooho a aona.

Boemo ba Sebelisoang Lefapheng bakeng sa Lesotho

Tlhokomeliso e bohlokoa: Boemo bona ba tsebisoa ke bopaki bo bontsoang karolong ea GENERAL KNOWLEDGE ea rona. Ha se merero ea bongaka, ha sa dumiswa ke FDA, le ha se sebakana sa kalafo ea bongaka e nang le phihlello. Ikopanye le mofani oa bophelo o nang le phihlello pele u sebelisa lihlahiswa tsa cannabinoid, hahola ha u na le mathata a bongaka, u sebelisa meriana, u mometse kapa u nyetsa. U se ke ua otlolla mechine kapa dithulagare ha u se ka tlase ea tshusumetso.

Bakeng sa baruihlooho ba lefuba ba Basotho (hahola ha ba lebisa Afrika Boroa bakeng sa kalafo):

• Peo ea chemo: 0.5-1.0mL sublingual ~1 hora pele ea kalafo
• Nausea e phahameng: 2-3 puffs tsa vape bakeng sa tšohelo e lebelo
• Mor’a chemo: 0.5mL sublingual lihora tse 6 le ka mora ho hloka
• Tšehetso ea toro: 1.0-2.0mL sublingual pele o robale (e fana ka CBN ea 25-50mg)
• Bohlokoa: Kopanya le sehlopha sa hao sa oncology mafapheng a bokoni jaaka Charlotte Maxeke Johannesburg Hospital kapa Groote Schuur. RSO e lokela ho tšoaea, e siyo tlohela, mekhoa e tšepahileng ea kalafo.

Bakeng sa lefuba le letlala (e tloaelehileng mosebetsing wa tšimo ea Basotho):

• Motsheare: 0.3-0.5mL sublingual e sa phehilweng — anti-inflammatory ntle ho impairment
• Bosiu: 0.5-1.0mL sublingual e kgonnnweng — tšohelo ea lefuba le tšehetso ea toro
• Lefuba le phahameng: Vape ha e le e hloka
• E shebelle mathata tse jwalo ka arthritis ho tloha dilemo tsa tšebeletso le tjhelete kapa majalefa ho tloha ho mosebetsing wa mining

Bakeng sa mathata a toro:

• Pele o robale: 1.0-2.0mL sublingual
• Ka 2.0mL: e fana ka CBN ea 50mg (tekanyo e hlahloailweng lengweling ea toro ea 2024)
• Ka 1.0mL: e fana ka CBN ea 25mg

Bakeng sa tlala le tšeno:

• Motsheare: 0.3mL sublingual e sa phehilweng — CBD le CBG di laetsa tlala ntle ho impairment
• Bosiu: 1.0mL sublingual — mofuta o felletseng o kenyang CBN

Mohato oa khetho oa tšoanang: Qala ka tlaase, sepela ka nako. Qala ka 0.25-0.5mL sublingual le lekola tshusumetso lihora tse 2-3 pele u eketsa. Karabo ya motho le motho e fapana ho latela boima ba ‘mele, metabolism, ho dumela, le meriana.

Ho Fihlela le Ho Fumaneha lefatšeng — Ho Fumana OilWell ho Lesotho

Ho Fihlela letsatsi le letsatsi Houston (bakeng sa ho utloisisa mosebetsi oa rona):

• Texas Medical Center: MAHALA (lihora tse 2-4)
• Inner Loop: $5 (lihora tse 2-4)
• Beltway 8: $10 (lihora tse 3-5)
• Greater Houston suburbs: $15 (lihora tse 4-6)

Ho Romela ka Bophara lefatšeng lohle

• Linaha tsohle tse 50 tsa US moo lihlahiswa tsa Farm Bill li laetswang ke molao
• USPS Priority Mail (lihora tse 2-3 tsa mosebetsi), FedEx/UPS Ground (matsatsi a 3-5)
• Ho romela lefatsheng lohle le dintlha tsohle, COAs, le dipokello tsa teko

Bakeng sa bareki ba Lesotho:
Re romela lefatsheng lohle ho mebuso moo lihlahiswa tsa hemp tse nang le <0.3% delta-9 THC li lumetsweng ke molao. O ikemiseditse ho lekodisa melao ea Lesotho e amanang le ho import hemp. Framework ea rona ea THCa e bolela hore sehlahiswa se dumetsweng ke Farm Bill nakong ea ho reka, empa bareki ba Basotho ba lokela ho netefatsa melao ea lehae pele ba odara.

Tshusumetso ea Customs le Molao:

• Re fana ka dintlha tsohle bakeng sa customs
• O amohela kotsi ya customs le molao ka moka
• Ikgopanye le rona: (832) 416-2816 kapa [email protected]
• Tekanyo e tlaase ea shipping e kenyeletswa; litšenyehelo tse fetileng ke tsa bareki

Bohlokoa ba ho fumana lefatšeng ha bo khonehe ho hlakajoa. Rick Simpson ha a kgonehe ho romela mafura a hae kae kapa kae — e ne e le Schedule I. Baruihloobo ba lefuba maseru, motho ea lebana le lefuba le letlala Teyateyaneng, kapa moqhubu Mohale’s Hoek ka joale ka kgona ho fumana formula e tšoanang ea multi-cannabinoid RSO eo baeng ba Houston ba e fumana letsatsi le letsatsi. Re hlahisitse sehlahiswa seo se kgona ho feta mehoa — ho fihlela mohato oa Simpson seo thibelo e neng e e etsa ho se kgonehe.

Hobaneng Li-formula tsa Rona E Amana le Bopaki

Cannabinoid e ‘ng le e ‘ng ka formula eona (CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC) e na le profile ya bona lengweling ea GENERAL KNOWLEDGE ea rona. Terpene e ‘ng le e ‘ng (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) e akarelletswe le bopaki ba preclinical le review-level.

Leqephe la tshoaro ea RSO ea rona le etsa likhathatso tse tšeletsweng ka lipaliloang tse fapakaneng, mme tlaleho ena e fana ka bokhoni ba ho netefatsa lengwelo — tse hlano tse tšoang tsa batho ba bang, tekanyo ea tier ea bopaki, le framework ea ho nka maikutlo a tšhabisano.

Hierarchy ea rona ea bopaki, ditshwantšho tsa ho khahlisa, le dintlha tsa tshireletso di sebetsa le lihlahiswa tsa rona. Ha re tlohelwe le standards tseno tse tšoanang re e fapanya le makoelo a cannabinoid a ka bophara. Sena se entsoe ka maikutlo. Jwaleka Collins a re ka 2019: batho ba lekane le tlahisoleseling e ka molemo ho feta ho e fa monyetla o lekaneng le ho ipalla hore na e nepahetseng kapa e fosahetse bakeng sa bona.

OilWell Cannabis e feta brand — e thepa e lokolohileng ho fumisa lihlahiswa tsa cannabis tse ka molemo tse tšoarehileng. Re sa teng mona ho latela mekgwa. Re teng mona ho li beha. Ha re hola, tshoaro ea rona e lula e tšoarela boitshwaro, bokgoni bo ikhethang, le tshebediso eo e behileng rona matsatsing a Bentley a ema, a sepela, le ho tlisa bolo ya hae ho bapala.

TSEBO E KAKARETSANG

Mokhoa oa Thuto le Boima ba Bopaki

Re ehlakolla bopaki ka tsela ena: bopaki ba motho, dintlha tsa review le meta-analysis, tlaleho ea NIH/lik’hamphani, mme lengweli la preclinical ha dintlha tsa motho di nyane. Sena se bohlokoa hobane basebopoi ha e le tšeo tse lekanang.

CBD le delta-9 THC di na le lengweli la motho le matla. Delta-8 THC, THCa, CBG, CBN, CBC, le terpenes tse ngata di dumela ho dintlha tsa review, mosebetsi oa liphoofolo, le lithuto tsa pharmacology [1]-[29].

Boemo oa Motheo ho tloha ho NIH

• NCCIH e bontsa hore bopaki bo matla ka ho feta ka cannabinoid ke bakeng sa epilepsy e ikhethang, nausea/vomiting eo e amanang le chemotherapy, le appetite/weight loss ea HIV/AIDS [1]
• Bopaki bo bonolo bakeng sa lefuba le letlala le liphumo tsa MS; mekgwa e mengata e sa tšoele pele [1]
• FDA ha e sa dumisa sehlahisoa sa cannabis ea sehlahisoa bakeng sa maboelelo a bongaka [1]
• Likahlano tsa tshireletso: ho hloka ho lemoha, kotsi ea ho otlolla koloi, mosebetsi wa cannabis oa tlala, likahlano tsa bophelo bo bontšha, tlaleho ea lapeng, ho kena ha ngwana lesea, kgwele, ho sa nepahetse ha label, vapis ea monko o hlaha [1]
• Dihlahiswa tsa CBD tse rekistsoang ka counter di ka fapana le label; e amanang le ho fokotsa ho lemoha, liphumo tsa GI, ho fosahetseha ha ebole, liphetoho tsa meriana [1]

Lipalilo tsa Cannabinoid

CBD

• Bopaki bo matla ka ho feta formula eona, haholo jwalo ka sehlahiswa se hlophisitsoeng [1]-[6]
• Tlala: Review e 2024 ea 316 ba karolo e fumane signal e bohlokoa ea anxiolytic empa baqapi ba hlokomela sample e nyane, ba hloka lithuto tse ngata [3]
• Lefuba: Review e 2024 e fetisitse hore e le bohlokoa empa e sa tšoanang, boleng ba thuto bo fokotsa tšepo [4]
• Toro: Review e 2023 ea insomnia e fumane lengweli le fokolang, ditekanyo tse nyane tse fanang le maikutlo [5]
• Tshireletso: Review e 2023 e fumane signal e nnete bakeng sa ho eketsa enzyme ea ebole le possible liver injury, haholo ha products e tsosolositsoeng le polypharmacy [6]; NCCIH e bonts’a diarrhea, ho robala, liphetoho tsa appetite, liphumo tsa mood, ho fosahetseha ha ebole, liphetoho tsa meriana [1]
• Tshwantšho: Cannabinoid e siyo intoxicating e nang le bopaki bo matla haholo, empa bopaki bo matla bo kopantsoe mekgwa e ikhethileng, e siyo dikhothatso tsa wellness [1]-[6]

CBG

• Bopaki: Review le preclinical ka ho fetisisa; bopaki ba motho bo nyane [7][8]
• Pharmacology: Precursor biosynthetic, pharmacologically e fapana le THC/CBD; e kopana le receptors ea cannabinoid, alpha-2 adrenoceptors, signaling ea 5-HT1A [7]
• Mebelelo ea thuto: Possible relevance ho mathata a neurologic, inflammatory bowel disease, antibacterial activity — haholo preclinical [7][8]
• Tlhokomeliso: Review e 2021 e bonts’a hore CBG e rekistsoe ha basebopoi bo fokolohile, likhothatso di feta sayense [7]
• Tshwantšho: Lihlooho tsa sebele tsa thuto, empa e lokela ho bonts’uwa e le cannabinoid e ntle le boitšoaro bo tšepahileng, e siyo therapeutic e netefaditsoeng [7][8]

Delta-8 THC

• Bopaki: Pharmacologically relevant, psychoactive, ha e lekantle ha e tšoahloa ho feta delta-9 THC [9]-[11]
• Comparative pharmacology: Review e 2022 e finyeletswe hore behavior e tšoanang le delta-9 THC; partial CB1 agonist, matla a fokolang ka lebaka la affinity e fokolang ea CB1 [9]
• Bophelo bo bontšha: Review e 2023 e fumane hore basebopoi bo fapana le liphoofolo, chemistry ea sehlahisoa, diteko tsa ho sebelisa, likahlano tsa bophelo bo bontšha ho feta thuto e matla ea motho; e bonts’a diketsahalo tse mata, e bolela hore bolao le boleng ba sehlahisoa bo bohlokoa [10]
• Tlhahiso: Review e 2024 e bonts’a hore thahasello ea khoebo e amanang le stability e eketsehileng/synthesis e bonolo ho feta lebelo la sehlooho; lipotso tsa product-byproduct le tlhahlobo ea maabara li bohlokoa [11]
• Tshwantšho: Phenomena ea THC e psychoactive le matla a pharmacologic, ha e lekantle ha e tšoahloa ka tshireletso, ha e bonolo ho feta seo bareki ba tsebang ka boleng ba tlhahiso [9]-[11]

THCa

• Bopaki: Bohlokoa ka chemistry/formulation, empa bonyane ho bopaki ba therapeutic ba motho ka mong [12]
• Se e leng sona: Precursor acid ea THC; e ka ba le karolo e kgolo ea THC-related content ho sehlahisoa se sa phehilweng; e decarboxylate ho ya ho THC nakong mocheso le ka nako ea ho boloka [12]
• Psychoactivity: THCa ka eona ha e etsa liphumo tse psychoactive, empa phapang e ba lebaka feela ha molek’hule e lula acid le ha e sa kgotsollwa ka moo [12]
• Boemo ba thuto: Lengweli la in vitro/liphoofolo la bonts’a kgololeleo ea anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic; ha e lekanne le liphumo tsa motho tse tšepahileng [12]
• Tshwantšho: Kgololeleo e bohlokoa ea precursor molecule mme ho utloisisa e lebisa ho mocheso, ho kgotsolla, ho boloka [12]

Delta-9 THC

• Bopaki: Bopaki bo matla ka ho feta ba cannabinoids tse psychoactive, empa le hlooo le bonolo la liphumo tse mata [1][13]-[15]
• Dumetsweng ke lik’hamphani: NCCIH e fumana hore meriana e nang le THC e amana le nausea/vomiting ea chemo, appetite/weight loss ea HIV/AIDS, liphumo tse ‘ngoe tsa MS/lefuba — e bolela hore mekgwa e mengata e siyo e tšoele pele [1]
• Bopaki ba lefuba: Review e 2022 e fumana hore lihlahiswa tse THC e phahameng kapa tse THC:CBD e tšoanang ka tsona di ka fana ka melemo ya letsatsi le lecha la lefuba empa di eketsa diziness, sedation, nausea, ho tlohela kalafo [13]
• Pharmacokinetics: THC e kgotsollwang: ho qala metsotsoana-metsotsoana, peak ~15-30 metsotsoana, ho fihla ha morao; THC e tloaeng: ho qala morao, peak morao, nako e telele — bohlokoa bakeng sa melemo le kotsi ea ho sebelisa haholo [14]
• Kotsi ea bokhabane: Review e 2025 ea lihlahiswa tse THC e phahameng e fumane dikamano tseo sa tšoanang le psychosis/schizophrenia le mosebetsi wa cannabis oa tlala; litshebeletso tsa tšitiso bakeng sa anxiety/depression mekgweng e siyo therapeutic [15]
• Tshireletso e bophara: Tlala/panic ha dosis e phahameng, pelo e potlakile, liphetoho tsa mali, bopotso, kotsi ea withdrawal, likahlano tsa bophelo bo bontšha, ho kena ngwana lesea, vapis ea monko o hlaha [1][14][15]
• Tshwantšho: Matla a therapeutic a bohlokoa mekgweng e mengata, empa le hlooo le bonolo la intoxication, psychiatric, le tshireletso e amanang le tekanyo [1][13]-[15]

CBN

• Bopaki: Bopaki bonyane; marketing e fetse pele ho dintlha [12][16][17]
• Se seo e marketiweng bakeng sa sona: Toro le sedation; reputation e phatlalalitse empa tšehetso ea kliniki e fokolola ho feta seo ‘marakeng le bonts’a [16][17]
• Review ea toro: Review e 2021 ea narrative e etsa thibela 99 abstracts, e sheba 8 articles, ha e fumane lithuto tsa motho tse sebelisang dipotšišo tse tšepahileng tsa toro kapa polysomnography ho netefatsa likhathatso tse matla tsa ho hlohleletsa toro [16]
• Lengweli la toro ka bophara: Review e 2024 e finyeletswe hore thuto ea toro ea cannabinoid e sa tšoane le ho sebeliswa lefatsheng; ho hloka lithuto tse nang le design e ntle, e matla [17]
• Boemo ba chemistry: Review e bonts’a hore THC e ka ba lebisa CBN ka mekgwa e ‘ngoe, e hlalosa hobaneng CBN e buuoa ho cannabis e meketsang/e oxidized [12]
• Tshwantšho: Mofuta o bonolo oa hloko moo reputation ea setso e matla ho feta bopaki ba kliniki ba kajeno [16][17]

CBC

• Bopaki: E tšabehang, e mphatsimalla, e fetile preclinical kapa review [18][19]
• Pharmacology: Review e 2024 e bonts’a pharmacodynamics, pharmacokinetics, receptor behavior tse fapakaneng; e bontsa antinociceptive, antibacterial, anti-seizure e le mebelelo e bohlokoa [18]
• Lengweli la kgale: Review e bontsa liphumo tsa anti-inflammatory, ho fokotsa gut hypermobility, ho fokotsa lefuba liphoofolo, possible neurobiological/antiproliferative — ha se bopaki bo matla bakeng sa likhathatso [19]
• Tlhokomeliso ea tshireletso: Review e 2024 ea CBC e bontsa hore lihlahiswa tsa CBC tsa over-the-counter di rekistsoe ha bopaki ba efficacy kapa tshireletso bo nyane [18]
• Tshwantšho: Cannabinoid e tšabehang e hloka thuto e ngata, e siyo therapeutic e tšepahileng [18][19]

Lipalilo tsa Terpene

Khopolo ea terpene e hloka ho nka maikutlo a tšhabisano ho feta cannabinoid. Lengweli le ngata le tsoa ho lihlahiswa tse arolwang, mafura a esense, lipapatso tse siyo cannabis, kapa lithuto tsa preclinical ho feta lithuto tsa motho tse khethiloeng tsa cannabis formulations. Review e 2024 ea entourage-effect: bioactivity ea terpene e lokolohileng le ka nako tse ling e mphatsimalla, empa bopaki bo matla ba entourage effects e le tsa bohlokoa bathong bo sa feleng [20][29].

Limonene

• Bopaki: Review le preclinical ka ho fetisisa, lengweli la tshireletso le bohlokoa [20]-[22]
• Possible activity: Review e 2021 e bonts’a limonene e le monoterpene multifunctional le antioxidant, anti-inflammatory, cardioprotective, gastroprotective, possible activities ea immune-modulatory; karolo e fetang e kana ha e sa tsoa ho literature ea nonhuman/non-cannabis [21]
• Tlhokomeliso ea tshireletso: Liproducts tsa oxidation ea limonene, haholo hydroperoxides, allergens tse bohlokoa tsa ho kopanya le letlalo ho literature ea patch-testing [22]
• Tshwantšho: Biologically active, e buuoa haholo, empa likhathatso tsa therapeutic tsa cannabis li lokela ho dula tsa tšoanang ha e sa tšeheloa hantle ho batho [20]-[22]

Myrcene

• Bopaki: Preclinical ka ho fetisisa, bopaki banyane ba motho [20][23]
• Summary ea thuto: Review e 2021 ea myrcene e bonts’a properties tsa anxiolytic, antioxidant, anti-inflammatory, analgesic, e buuoa mechanisms; e bontša haholo hore lithuto tsa motho di hlotsoe [23]
• Tlhokomeliso ea ho nka maikutlo: Myrcene e buuoa haholo e le terpene e tšepahileng e bohlokoa e hlalosa couch-lock/effects ea toro; khathatso e matla ho feta bopaki ba motho ha joale [20][23]
• Tshwantšho: Terpene e lokolohileng, empa likhathatso tse tsoanang tsa setso ka mood, pain, sedation di fetile bopaki bo bonolo ba motho [23]

Caryophyllene

• Bopaki: E tšoanang le ho fetisisa ka lebaka la cannabinoid-system relevance, empa e sa hlophisweng haholo [24]
• Hobaneng e tšoana le tse ling: Review e 2021 e bonts’a beta-caryophyllene e le selective CB2 receptor agonist, e kgethela, e bohlokoa ha e buuoa terpenes tsa cannabis pharmacologically hlohlong ea pure aromatic [24]
• Mebelelo ea thuto: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions di buuoa haholo; netefatso ea motho e fokolang [24]
• Tshwantšho: Likhaolo tse matla ka ho fetisisa bakeng sa terpene le significance ea cannabinoid-system, empa e siyo therapeutic e netefaditsoeng ka kliniki bakeng sa liphumo tse buuoang [24]

Pinene

• Bopaki: Lengweli la preclinical le mphatsimalla, netefatso e fokolang ea kliniki [20][25]
• Framing ea bokhabane: Review e 2021 ka pinene le linalool e le terpene-based medicines bakeng sa bokhabane e fumane signals tsa antioxidant, anti-inflammatory, neuroprotective e hloka thuto; e bontša hore bopaki bo feta preclinical, lithuto tse nang le design e ntle di hlotsoe [25]
• Tlhokomeliso: Likhathatso hore pinene e ntšha memory, e ruta ho lemoha, kapa e hlwekisa effects ea cognition ea THC di hypotheses e lokolohileng eseng lints’ebeletsong tse tšepahileng tsa kliniki [20][25]
• Tshwantšho: E hloka ho shebelloa ka ho eketsehileng, empa likhathatso tse matla tsa cognition li lokela ho bonts’uwa e le tse lokolohileng eseng lints’ebeletso tse tšepahileng [25]

Linalool

• Bopaki: E tšoana le pinene: thuto e matla preclinical, netefatso e nyane e tsoa ho kliniki [20][22][25][26]
• Summary ea thuto: E buuoa haholo mabakeng a stress, mood, pharmacology ea bokhabane; review e 2021 ea bokhabane e fumane signals e lekaneng ea preclinical e hlokang thuto e tšabehang ha e le psychiatric/neurological mme e bontša lack ea robust human trials [25]
• Lengweli le ling: Review e fapahaneng e buuoa ka possible antidepressant mechanisms, neuropharmacologic relevance; e sa le tsohle eseng clinical story [26]
• Tlhokomeliso: Jwaleka limonene, oxidized linalool hydroperoxides di allergy tse tsebahalang ho literature ea dermatitis [22]
• Tshwantšho: Terpene e lokolohileng le credible eseng therapeutic e netefaditsoeng ka kliniki [22][25][26]

Humulene

• Bopaki: Translationally e mphatsimalla, empa e sa qaleng [20][27]
• Findings ea scoping-review: Review e 2024 e shebile lipampiri tse 340, fumane bopaki bo bophara ba preclinical bakeng sa anti-inflammatory le liphumo tse ling; mosebetsi o ‘ngoe wa liphoofolo o bonts’a cannabimimetic properties ho tloha ho CB1 le ditsela tsa adenosine A2a [27]
• Tlhokomeliso ea ho nka maikutlo: Dintlha tse bohlokoa bakeng sa hypothesis generation, empa ha se netefatso consistency ea efficacy ea motho mekhoeng eohle ea lefuba, inflammation, mood [27]
• Tshwantšho: E ‘ngoe ea terpenes tse nang le thuto e mphatsimalla, empa e krale ho netefatso ea kliniki [27]

Terpinolene

• Bopaki: E ‘ngoe ea terpenes tse ka tlase ka ho fetisisa clinically characterized ka file ena [20][28]
• Findings ea systematic-review: Review e 2021 ea terpinolene e shebile 2,449 records, e kenyeletsa 57 lithuto, e finyeletswe ho liphumano tse fapakaneng tse buuoeng; basebopoi bo fapana le in silico, in vitro, lithuto tsa liphoofolo eseng trials ea motho [28]
• Tlhokomeliso: Review tse fosahetseng tsa cannabis entourage di beha melemo ea terpene e le lokolohileng, eseng liphumo tse tšepahileng tsa compound-specific clinical effects [20]
• Tshwantšho: Biologically e mphatsimalla, empa har’a terpenes tse buuoeng e sa hlophisweng haholo [20][28]

Likgetlo le Ho Arabela

• Basebopoi bo fapana haholo; CBD le delta-9 THC di tšehetsa likhathatso tse bonolo tsa motho; tse ling di hloka tlhokomeliso e eketsehileng [1]-[29]
• Dintlha tsa khethollo e felletseng ea cannabis, purified molecule, semisynthetic, terpene-only ha di arolelane; phoso e tloaelehileng ke ho laetsa bopaki ho tloha ho sete e mong ka e ‘ngoe
• Boleng ba sehlahisoa bo bohlokoa jwaleka ha lebitso la molek’hule: inaccuracies labeling, kgwele, byproducts, variability ea dosis, pharmacokinetics e amanang le route e hlokeha ho arabela ka tsela e fosahetseng [1][10][11][14]
• Bakeng sa THCa haholo, chemistry ke tshoelo-pele: ho boloka le mocheso di ka fetisa mofuta oa acid ho ditsela tse sa psychoactive tse jwalo ka THC [12]

Likhathatso Tse Tloaelehileng Tse Lokelang Ho Tlohelwa

• Khopolo e khahlisang: CBN ke cannabinoid e netefaditsoeng ea toro.
  E matla: Bopaki ba toro ba CBN bo sa feleng, ha sa tšoele pele [16][17]
• Khopolo e khahlisang: Myrcene ke sedative e netefaditsoeng e hlalosa couch-lock.
  E matla: Myrcene e na le bioactivity e lokolohileng, empa bopaki ba motho bo bonolo [20][23]
• Khopolo e khahlisang: Terpenes ka kakaretsō e na le entourage effects e netefaditsoeng.
  E matla: Hypothesis ya entourage e bohlokoa le worth studying, empa bopaki bo matla bo sa feleng le bo sa lekanang [20][29]
• Khopolo e khahlisang: THCa ha e psychoactive.
  E matla: THCa ka eona ha e THC, empa mocheso/processing o ka fetisa THCa ho ya ho THC [12]
• Khopolo e khahlisang: Delta-8 THC e tshireletse hobane e tsoa ho hemp.
  E matla: Delta-8 THC psychoactive, pharmacologically e tšoana le delta-9 THC, e nang le mathata a a tšwanang le manufacturing/testing [9]-[11]

Dintlha tsa Bohlokoa bakeng sa Li-formula tsa Rona

• Active e matla ka ho fetisisa: CBD le delta-9 THC
• Delta-8 THC ha e tšoane le psychoactive kapa pure mild; psychoactive cannabinoid le characterization e sa feleng tsa tshireletso/efficacy ho feta delta-9 THC
• THCa e fetisa ka mocheso; ha e lokelang ho arabelwa tšoanang ka mofuta o sa phehilweng, o hlokomelwang, o phehilweng
• CBG, CBN, CBG e credible ka sayense empa e sa tšoaneng le CBD/THC ka ho tšoahloa
• Terpenes tse buuoang e ka ba e le tsa bohlokoa ho aroma, flavor, possible biologic activity, empa compound-specific therapeutic claims di lokela ho etsoa hantle le ha di tšehetsoe hantle

FORMULA EA RSO SUBLINGUAL OIL

Cannabinoid	Tekanyo
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Cannabinoids ka Kakaretsō	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Mofuta: Bottle ea 30mL (1 fl oz)
• Cannabinoids tse sebetsang ka mL: 553mg
• Carrier: Organic MCT oil
• Ho qala: 15-45 metsotsoana
• Nako: 4-6 lihora
• Bioavailability: 13-19%
• Tekanyo: Dropper e felletsweng ka 0.1mL increments
• Theko: $129.99

Bakeng sa Basotho: Ena ke formula e felletseng. Milligram e ‘ng le e ‘ng e ngotsoe. Ha u ka kgona ho fumana li-cannabinoid distillates tse fapakaneng, u ka e etsa. Ha u reka ho rona, u fumana sehlahiswa se hlahloileng ke maabara, se tšoarwang ka maemo le tsebiso e felletseng.

FORMULA EA RSO VAPE CARTRIDGE

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Mofuta: Cartridge ea 1-gram
• ** Compatibility:** 510-thread universal batteries
• Ho qala: 1-2 metsotsoana
• Nako: 2-4 lihora
• Bioavailability: 10-35%
• Theko: $49.99

Bakeng sa Basotho ba batlang tšohelo e lebelo: Mohlala oa vape o fumana cannabinoids ka 1-2 metsotsoana, e nepahetseng bakeng sa lefuba le phahameng, nausea e phahameng, kapa ho tšohile. Puff e ‘ng le e ‘ng e decarboxylates THCa ho ya ho delta-9 THC.

MOFUTA OA TERPENE (LIHLahiswa TSOHLE)

Mofuta oa rona oa terpenes tse supileng o tšoanang mafapeng ohle:

• Limonene: Monko o citrus-bright, o hlohleletsang
• Myrcene: Monko o earthy, musky
• Caryophyllene (β-caryophyllene): Pepere/spice, CB2 receptor agonist
• Pinene: Monko o forest-fresh, o hlohleletsang ho lemoha
• Linalool: Floral (lavender), o tšitisang
• Humulene: Earthy, woody, matla a anti-inflammatory
• Terpinolene: Piney, fruity, complexity

Bakeng sa Basotho: Terpenes tsena di etsa tsebo ya monko e kopantsweng le monko a tsebo — li-citrus fruits tsa ‘maraka oa hao, pine ho tloha ho likharafi tsa Lesotho, monko a lavender, spices ea pepere. Lengweli la entourage effect [20][29] le bonts’a hore terpenes tsena di ka tšoaea cannabinoids, le ha bopaki bo matla ba motho bo sa feleng. Seo se tsejoa ke hore di etsa boiphihlelo ba sehlahiswa bo monate le bo authentic.

LIFINAL WORDS BAKENG SA LESOTHO

Basotho le bone cannabis e hola lefapheng la lona la likharafi bakeng sa libeso. Le shebile khoebo ea hemp ea iketsang ea Lesotho e ntsa. Le utsoe litokomane ka RSO likohelong tsa tšehetso ea lefuba maseru kapa har’a basebeletsi ba tšoanang metseng.

Se re se fana ka sona se fapana: boletswe, bopaki, le tshusumetso.

• Boletswe: Re ngola milligram e ‘ng le e ‘ng. Ha ho liri. Ha ho mixtures tse lekanyelletsweng.
• Bopaki: Re re se se tsejang sayense e reng — le seo e se reng.
• Tshusumetso: O kgetha hore na meriana ya hao e psychoactive kapa e siyo.

Ha re kgone ho romela Lesotho ha lihlahiswa tsa rona ha li sa tšoane le melao ea lona. Ha re kgone ho tiisa pholoso moo sayense e sa e tiisitse. Ha re kgone ho sebakana la morero oa ngaka oa hao.

Se re se kgona ho se etsa:

• Fumisa formula e ntlafatsweng kakhulu, multi-cannabinoid RSO e fumanehang
• Fana ka tsebiso e felletseng ho etsa dikgetho tse tsebang
• Etsa tsela e laetsweng ke molao ya bongaka ba cannabis ka chemistry ea THCa
• Hlompha bohlale le tokelo ya hao ya ho kgetha

Ikgopanye le rona:

• Mohala: (832) 416-2816
• Email: [email protected]
• Websaete: https://oilwellcbd.com/

Lilomo tsa lilemo: 21+ bakeng sa lihlahiswa tsohle tsa RSO

Tlhokomeliso ea FDA: Dintlhelo tsena di sa hlahlojwe ke Food and Drug Administration. Lihlahiswa tsena ha li na intention ya ho diagnose, treat, cure, or prevent any disease. Diphumo di fapana ka motho. Kgopela mofani oa bophelo pele u sebelisa.

Tlhokomeliso ea molao: Moreki o ikemiseditse ho lekodisa hore na sehlahiswa se dumetsweng ka molao mofuthong oa hae. Bareki ba Lesotho ba lokela ho netefatsa melao ea lehae pele ba odara. Re fana ka dintlha tsohle empa re se amohele kotsi ea ho kganna ke customs kapa mathata a molao. Tsoale moo molao o thibetswang.

Tlhokomeliso ea tshireletso: E ka bakela ho robala kapa ho hloka ho lemoha. U se ke ua otlolla mechine kapa dithulagare ha u se ka tlase ea tshusumetso. Boloka e le hae ho sa kena bana. Ha u mometse kapa u nyetsa, kgopela ngaka pele u sebelisa.

Bakeng sa sechaba sa Lesotho: Le ha u le litoropong tse tšoahalang tsa Maseru, tsa likharafi tsa Mokhotlong, kapa tsa tšimo ea Butha-Buthe, o lekane ho fumana thuto e nnete ea cannabis le lihlahiswa tse nang le boleng. Re e tšepa hore tlaleho ena e tla o sebeletsa hantle.

ENGLISH

Rick Simpson Oil (RSO) in Lesotho: The Complete Guide by OilWell Cannabis

Understanding Rick Simpson Oil in the Mountain Kingdom

Who is Rick Simpson, and Why Does His Story Matter to Lesotho?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada — a small town half a world away from Lesotho’s majestic Maloti-Drakensberg ranges. He wasn’t a doctor, scientist, or medical professional. He was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering. In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. When he asked his physician about cannabis, the request was refused.

This experience resonates deeply across Lesotho’s healthcare landscape. Many Basotho face similar frustrations with the medical system — long waits at Queen ‘Mamohato Memorial Hospital, limited specialist access in rural districts like Qacha’s Nek or Mokhotlong, and prescription cycles that sometimes cause more harm than relief. The story of a working-class person taking health into their own hands when institutional medicine fails is universal, whether in Nova Scotia or Maseru.

Simpson’s interest in concentrated cannabis oil deepened after learning about a 1974 study funded by the National Institute of Health that reported THC could slow tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference point for Simpson, even though its findings were never replicated in controlled human cancer trials.

The pivotal moment came in 2003 when Simpson claimed that applying concentrated cannabis oil to three bumps on his arm diagnosed as basal cell carcinoma made them disappear within four days. No independent medical verification was published, no biopsy confirmation documented. Yet this personal experience became the origin story of Rick Simpson Oil and launched a global movement.

Important context for Lesotho readers: Simpson’s account is personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as scientific proof. They are, however, historically significant as the catalyst for a worldwide movement around concentrated cannabis oil that has reached even our remote mountain kingdom.

The Crusade — How RSO Spread from Canada to Lesotho

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others, never charging a cent. By his account, he helped people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more.

His story reached global audiences through the 2005 documentary Run From The Cure, which became foundational in cannabis communities worldwide. Within Lesotho’s growing cannabis advocacy circles, this documentary has been shared quietly among patients seeking alternatives when Mohlomi Hospital or other facilities have limited options.

Simpson’s advocacy brought him into conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and 2009, eventually forcing him to leave Canada for Europe. This legal persecution mirrors experiences many Basotho have faced with cannabis prohibition — though Lesotho has made progress with industrial hemp cultivation, personal cannabis use remains legally complex. The fear of legal consequences has historically kept many Basotho from exploring cannabis medicine, making legal, lab-tested products like OilWell’s especially important for our community.

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his advocacy platform. His position remained uncompromising: he maintained that cannabis oil could cure cancer and that pharmaceutical companies and governments were suppressing this knowledge.

Important context for Basotho readers: Simpson’s conspiratorial framing reflects a worldview shared by many in the early cannabis movement and is relevant to understanding RSO’s cultural significance. However, it should not be confused with medical evidence. Basotho deserve honest education, not hype — especially when facing serious health decisions at institutions like Motebang Hospital or Teyateyaneng Government Hospital.

The Traditional RSO Protocol — What Basotho Need to Know

Simpson’s core recommendation was consuming 60 grams of concentrated cannabis oil over approximately 90 days. For Lesotho residents considering this approach, understanding the details is critical:

Titration Schedule

• Week 1: Half a grain of rice-sized dose (10-15mg) three times daily
• Weeks 2-5: Double every four days until reaching 1 gram per day
• Weeks 5-12: Maintain 1 gram daily, divided into three doses

Administration Methods

• Oral: Primary method — place under tongue or swallow
• Topical: For skin issues, apply directly with bandages
• Inhalation: Not recommended as primary treatment

Important Context for Lesotho

This protocol was designed for crude, unstandardized material. Several critical points apply:

• No controlled trial validation — no published studies evaluating this specific protocol
• Very high THC exposure — 600-900mg delta-9 THC daily at peak dosing, far exceeding anything studied clinically
• Real risks — severe intoxication, anxiety, tachycardia, cannabis use disorder
• Oncology complexity — patients at Lesotho’s cancer treatment facilities (like those referred to South Africa for radiation therapy) are medically complex

For Basotho cancer patients, using unregulated cannabis oil as a primary treatment — potentially in place of proven therapies — introduces harm that extends beyond the oil itself. Any consideration of RSO should complement, not replace, conventional care from qualified oncologists.

What Traditional RSO Actually Was

Traditional RSO was defined by Simpson’s method, not lab standards:

• Source material: Single high-THC indica strain, no standardization
• Extraction solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol — neither food-grade
• Extraction process: Bucket, solvent wash, filter, rice cooker evaporation, syringes
• Appearance: Nearly black, thick, tar-like oil with possible solvent-residual smell
• Cannabinoid profile: 60-90% THC, fully decarboxylated, uncontrolled minor cannabinoids
• Terpene content: Minimal to none — destroyed by heat
• Standardization: None — every batch different
• Residual solvent risk: Naphtha may contain benzene, toluene, carcinogens

For Basotho DIY makers in villages from Thaba-Tseka to Mohale’s Hoek, this safety information is crucial. Traditional methods carry real risks that modern, lab-tested products eliminate.

Simpson’s Claims vs. Evidence — What the Science Actually Says

Simpson claimed RSO could cure cancer and many diseases. Let’s examine what the evidence shows:

What the Preclinical Literature Shows

• In vitro studies demonstrate THC and CBD can induce apoptosis and inhibit tumor proliferation in certain cancer cell lines
• Animal models show some tumor-growth inhibition
• These findings generate legitimate scientific interest

What It Does NOT Show

• No human clinical trial has demonstrated RSO cures cancer
• The gap between animal results and human outcomes is vast
• No randomized controlled trials support the 60-gram protocol

Institutional Positions

• U.S. National Cancer Institute: Acknowledges cannabinoid anticancer research but does not endorse cannabis as cancer treatment
• FDA: Has not approved any cannabis plant product for cancer treatment
• Health Canada: Never approved RSO for cancer
• NCCIH: Strongest evidence is for epilepsy, chemo nausea, and HIV/AIDS appetite — not cancer cure

For Lesotho’s healthcare system, which follows many international guidelines, these institutional positions matter. They reflect the consensus view that while cannabinoid research is promising, cure claims exceed current evidence.

What Simpson Got Right

He drew attention to cannabinoids as serious biomedical research when the world ignored them. He helped create conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated

The leap from preclinical signals to cancer cure was not supported then and is not supported now. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential. For Basotho facing cancer diagnoses, delaying or foregoing treatment at facilities like Queen ‘Mamohato Memorial Hospital or seeking care in South Africa can have irreversible consequences.

ABOUT OILWELL CANNABIS AND THE OILWELL RSO FORMULA

The Origin Story — From McAllen to Maseru

OilWell Cannabis was founded by Colin Valencia in Houston, Texas — a city as hot and vibrant as Maseru on a summer day. But Colin’s roots trace back to McAllen, Texas, right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa Borderplex is one of America’s most economically challenged and dangerous regions — a place where poverty and cartel violence shape daily life. By sixteen, Colin had left home, having witnessed violence most Basotho can only imagine.

Despite these dangers, Colin chose cannabis over darker paths. He grew up in the traditional cannabis world pre-legalization, learning the plant intimately. Later, he became a formally trained software engineer, doing custom development for Baylor College of Medicine — one of America’s most prestigious medical institutions. That combination of deep plant knowledge plus medical-grade technical precision defines OilWell’s approach.

Bentley — The Dog Who Started Everything

OilWell’s origin story begins with a dog named Bentley. More than a pet, Bentley was family. When veterinarians delivered the verdict no owner wants to hear — euthanasia was the only humane option for his paralysis — Colin refused to accept it. Bentley was a fighter, just like him.

A rescue worker named Jessica asked the question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” Colin’s cannabis experience had been recreational; he’d never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Colin created a CBD golden paste for Bentley. It wasn’t a cure, but it was hope. And that hope delivered what veterinary medicine said was impossible: Bentley got up, walked over, and brought Colin his ball. From paralyzed facing euthanasia to fetching — this was not placebo. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure reduction
• Arthritis → Multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. This decade of real-world formulation testing on a beloved companion — more authentic than any clinical trial marketing claim — is the foundation of OilWell’s RSO formula.

Colin’s Personal Journey — PTSD and Benzo Addiction

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to quit Xanax cold turkey — notoriously difficult and dangerous — he used the cannabinoid knowledge developed keeping Bentley alive.

The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD. This is not theoretical knowledge; he lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

For Basotho veterans who served in peacekeeping missions or experienced trauma, this personal experience makes OilWell credible in a way no corporate brand can be. For those in Lesotho’s high-stress urban environments or rural isolation, this story resonates.

Formulas Used by Doctors

Over time, the therapeutic benefits Colin discovered became the core of his work. He’s developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been on making cannabis accessible for everyone, including vegans, diabetics, and those with specific health needs.

While Lesotho’s medical system differs from Houston’s, the principle remains: healthcare providers increasingly recognize cannabinoid potential. If you’re consulting a doctor in Maseru or a traditional healer in your village, having evidence-based information helps facilitate informed conversations.

ABC13 Houston — Seven Features, Four Years, Five Reporters

Between September 2019 and April 2023, ABC13 Houston featured Colin and OilWell Cannabis in seven distinct news segments. Five different reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. No other Houston cannabis operator appears with that frequency or breadth.

This mainstream media validation from a major ABC affiliate establishes credibility that transcends geography. When Basotho research OilWell, they find independent, editorially controlled news coverage — not marketing materials. This recognition cannot be purchased; it can only be earned.

OilWell’s Foundational Philosophy

In September 2019, Colin told ABC13: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This quote captures everything. It explains why we publish our formulas. Why we document the evidence. Why we’re honest about what we don’t know. For Basotho facing health crises, this honesty is more valuable than false certainty.

OilWell Today — A Real, Licensed Business

OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). Since 2019, we’ve generated approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. All artwork, formulations, and packaging are created in-house in Houston using only our own recipes and ideas.

For Lesotho customers, this means you’re dealing with a legitimate, successful, licensed business — not a fly-by-night operation. Our operational details are verifiable and independently documented.

The OilWell RSO Philosophy — Four Core Principles

OilWell’s RSO is not traditional Rick Simpson Oil. It is informed by the tradition but deliberately different in ways that solve problems traditional RSO couldn’t address:

1. Accessibility over gatekeeping

• No medical card required
• Age 21+ only
• Ships nationwide across the US and internationally to verified legal jurisdictions
• For Lesotho: if hemp-derived products with <0.3% delta-9 THC are legal in your jurisdiction, we can ship to you

2. Patient-controlled potency

• THCa is sold in its acidic, non-psychoactive form
• You decide whether to use it raw (non-psychoactive) or decarboxylate it into delta-9 THC
• For Basotho who work, drive, or parent: daytime functional use is possible with zero impairment
• For those seeking therapeutic strength: nighttime activation delivers full potency

3. Open-source formulas

• We publish our complete formulas publicly
• If you cannot afford our products, you can source ingredients and make your own
• This echoes Simpson’s free-distribution ethos for the modern marketplace

4. Evidence-informed, not evidence-overstating

• This document represents our commitment to honest education
• We distinguish between what is well-supported, emerging, and overstated
• You deserve the truth, not hype

The Bentley Recipe — Our Original Open-Source Formula

Before we published the RSO formulas, we published the CBD golden paste recipe that saved Bentley:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper
• CBD oil (dosage depends on size and needs)

Instructions:

1. Mix turmeric and water in saucepan, stir over low heat until thick paste forms (7-10 minutes)
2. Add coconut oil and pepper, stir until thoroughly mixed
3. Cool and store in jar with lid (refrigerate up to two weeks)
4. Add CBD oil before giving to pet

Serving: Mix small amount with pet’s food once or twice daily. Consult veterinarian.

This recipe demonstrates our open-source philosophy is foundational, not marketing. For Basotho pet owners facing similar crises, this is immediately useful.

Farm Bill Compliance and the THCa Legal Framework

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC at the federal level in the US. This framework makes our products possible.

Our RSO Sublingual Oil contains only 90mg delta-9 THC in the entire 30mL bottle (3mg/mL) — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in most states.

For Lesotho customers: You are responsible for verifying legality in your jurisdiction. We ship with full documentation, Certificates of Analysis, and receipts. Basotho customers accept all customs and legal responsibility. If hemp-derived products with <0.3% delta-9 THC are permitted in Lesotho’s legal framework, we can deliver to you.

The Decarboxylation Choice — Your Power

Traditional RSO was always fully decarboxylated. You had no choice about psychoactivity.

Our sublingual formula contains 1,500mg THCa in its acidic, non-psychoactive form. This creates three usage options:

Option 1 — Raw, no heat: All 1,500mg stays as THCa — completely non-psychoactive. Provides anti-inflammatory and neuroprotective potential without impairment. Perfect for daytime use in Maseru’s business district or farming in Leribe.

Option 2 — Fully activated, home decarboxylation: Heat oil at 260°F (125°C) for 45-60 minutes in oven-safe glass container. Converts 1,500mg THCa to approximately 1,315mg delta-9 THC. Combined with existing 90mg, yields ~1,405mg total delta-9 THC. This delivers psychoactive potency comparable to traditional illegal RSO, 100% legally because activation occurs after purchase.

Option 3 — Vape, auto-decarboxylation: Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Fastest-onset RSO delivery available.

Conversion chemistry: 1mg THCa = 0.877mg delta-9 THC after decarboxylation (loss of CO₂ molecule).

This design puts the potency decision entirely in your hands — aligning with Simpson’s principle that patients should control their medicine, but implementing it through actual chemistry.

Solvent-Free Production — Safety First

Traditional RSO used naphtha or isopropyl alcohol — toxic solvents that may contain benzene, toluene, and carcinogens. Incomplete purging leaves harmful residues.

Our RSO is not an extraction product. It’s a formulated blend of individual cannabinoid distillates and isolates combined in a controlled environment. No naphtha. No isopropyl alcohol. No butane.

We use organic MCT oil as carrier base — food-grade, facilitates absorption, neutral taste. This is a significant improvement over traditional RSO’s tar-like consistency and solvent odor.

Third-party lab testing covers:

• Cannabinoid potency
• Terpene profile
• Pesticides
• Heavy metals
• Residual solvents
• Microbial contaminants

Certificates of Analysis (COAs) are available on request. For Basotho customers, this testing documentation provides confidence that products meet international safety standards.

The Broader OilWell Portfolio

Beyond RSO, we produce products born from Colin’s formulation knowledge:

Asshole Peach — Our most popular product, particularly favored by veterans for PTSD and pain relief. Delivers euphoric, long-lasting sensation without being overly aggressive.

Peace Gummies — Developed from Colin’s personal benzo withdrawal experience. Available in vape form for quick relief. Colin personally uses this for insomnia and severe PTSD.

Custom creations — We design tailored products for specific cannabinoid ratios, delivery formats, or health circumstances, including formulations for vegans, diabetics, and those with specific needs.

While some of these may not ship internationally, they demonstrate our formulation expertise and commitment to personalized medicine.

Two Product Formats — Choose Your Path

RSO Sublingual Oil — $129.99

• 30mL bottle, 16,590mg total cannabinoids (553mg/mL)
• Seven cannabinoids: CBD 4,500mg, CBG 3,000mg, delta-8 THC 6,000mg, THCa 1,500mg, delta-9 THC 90mg, CBN 750mg, CBC 750mg
• Live terpenes at 5%
• Organic MCT oil base
• Graduated dropper (0.1mL increments)
• Onset: 15-45 minutes, Duration: 4-6 hours
• Bioavailability: 13-19%
• Approximately 40-60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge, 900mg+ total cannabinoids
• Six cannabinoids (same ratio as sublingual, minus separate delta-9 THC — THCa auto-decarbs at vaping temp)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes, Duration: 2-4 hours
• Bioavailability: 10-35%
• Instant THCa decarboxylation at 400-450°F

When to Use Each Format

Use Case	Recommended Format	Why
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability/discretion	Vape	Compact, no measuring
Precise dosing control	Sublingual	Graduated 0.1mL dropper
Daytime non-psychoactive	Sublingual (raw)	THCa stays inactive
Nighttime psychoactive	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

Competitive Landscape — Why OilWell Stands Out

OilWell RSO vs. Traditional Illegal RSO

• 7 defined cannabinoids vs. uncontrolled single-strain
• Lab-tested vs. no testing
• Solvent-free vs. naphtha/isopropyl risk
• Patient-controlled potency vs. always psychoactive
• Published formula vs. secret recipe
• Legal vs. Schedule I

OilWell RSO vs. CBD-Only Products

• 16,590mg total cannabinoids vs. typical 1,000mg
• Multiple therapeutic pathways vs. single compound
• Psychoactive option available vs. non-psychoactive only
• Complete terpene profile vs. minimal terpenes

For Basotho, this means you’re getting the most advanced, transparent RSO formulation available — one that respects Simpson’s vision while solving its fundamental problems.

Condition-Specific Usage Context for Lesotho

Important disclaimer: These contexts are informed by research cited in our GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved, and not substitutes for professional medical care. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have medical conditions, take medications, are pregnant or nursing. Do not operate vehicles or machinery while under the influence.

For Basotho cancer patients (especially those traveling to South Africa for treatment):

• Pre-chemo: 0.5-1.0mL sublingual ~1 hour before treatment
• Breakthrough nausea: 2-3 vape puffs for immediate relief
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Critical: Coordinate with your oncology team at facilities like Charlotte Maxeke Johannesburg Hospital or Groote Schuur. RSO should complement, not replace, proven therapies.

For chronic pain (common in Lesotho’s agricultural workforce):

• Daytime: 0.3-0.5mL raw sublingual — anti-inflammatory without impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual — pain relief plus sleep support
• Breakthrough pain: Vape as needed
• Consider for conditions like arthritis from decades of field work or injuries from mining labor

For sleep disorders:

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: delivers 50mg CBN (dosage studied in 2024 sleep literature)
• At 1.0mL: delivers 25mg CBN

For anxiety and stress:

• Daytime: 0.3mL raw sublingual — CBD and CBG address anxiety without impairment
• Nighttime: 1.0mL sublingual — full profile including CBN

General titration principle: Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, and medications.

Delivery and Global Accessibility — Getting OilWell to Lesotho

Houston Same-Day Delivery (for context on our operations):

• Texas Medical Center: FREE (2-4 hours)
• Inner Loop: $5 (2-4 hours)
• Beltway 8: $10 (3-5 hours)
• Greater Houston suburbs: $15 (4-6 hours)

Nationwide and International Shipping

• All 50 US states where Farm Bill products are legal
• USPS Priority Mail (2-3 business days), FedEx/UPS Ground (3-5 days)
• International shipping with full documentation, COAs, and receipts

For Lesotho customers:
We ship internationally to jurisdictions where hemp-derived products with <0.3% delta-9 THC are permitted. You are responsible for verifying Lesotho’s specific regulations regarding hemp product importation. Our THCa legal framework means the product is Farm Bill compliant at point of sale, but Basotho customers must confirm local laws before ordering.

Customs and Legal Responsibility:

• We provide complete documentation for customs
• You accept all customs and legal risk
• Contact us: (832) 416-2816 or [email protected]
• Minimum flat-fee shipping applies; excessive costs are customer-responsible

The significance of international access cannot be overstated. Rick Simpson couldn’t ship his oil anywhere — it was Schedule I. A cancer patient in Maseru, a chronic pain sufferer in Teyateyaneng, or a veteran in Mohale’s Hoek can now access the same clinical-strength multi-cannabinoid RSO formula that Houston patients receive same-day. We built a product that can legally cross borders — completing a piece of Simpson’s vision that prohibition made impossible.

How Our Formulas Connect to the Evidence

Every cannabinoid in our formula (CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC) has its evidence profile in our GENERAL KNOWLEDGE section. Every terpene (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) is covered with preclinical and review-level evidence.

Our RSO guide page makes specific research claims about individual compounds, and this document provides the source evaluation context — the same peer-reviewed citations, evidence-tier assessments, and cautious interpretation framework.

Our evidence hierarchy, overstatement warnings, and safety notes apply equally to our own products. We don’t exempt ourselves from the same standards we apply to the broader cannabinoid field. That’s intentional. As Colin said in 2019: people deserve the best possible information so they can give it a fair shot and decide for themselves if it’s right or wrong.

OilWell Cannabis is more than a brand — it’s a promise to deliver the best, most thoughtful cannabis products available. We’re not here to follow trends. We’re here to set them. As we grow, our focus remains on maintaining the integrity, creativity, and commitment that defined us from the day Bentley got up, walked across the room, and brought his ball to play.

GENERAL KNOWLEDGE

Research Method and Evidence Weighting

We prioritize evidence in this order: human clinical evidence, systematic reviews and meta-analyses, NIH/institutional summaries, then preclinical literature when human data are sparse. This matters because the evidence base is uneven.

CBD and delta-9 THC have the strongest human literature. Delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and pharmacology studies [1]-[29].

Institutional Baseline from NIH

• NCCIH states strongest cannabinoid evidence is for certain rare epilepsies, chemotherapy-related nausea/vomiting, and HIV/AIDS appetite/weight loss [1]
• Modest evidence for chronic pain and MS symptoms; many other uses remain early-stage [1]
• FDA has not approved cannabis plant itself for medical use [1]
• Safety concerns: impairment, vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, labeling inaccuracy, vape lung injury [1]
• Over-the-counter CBD products may differ from labels; associated with decreased alertness, GI effects, liver abnormalities, drug interactions [1]

Cannabinoid Profiles

CBD

• Strongest evidence in our formula, especially as purified product [1]-[6]
• Anxiety: 2024 systematic review of 316 participants found significant anxiolytic signal but authors stress limited clinical sample, need more trials [3]
• Pain: 2024 systematic review concluded promising but heterogeneous, trial quality limits confidence [4]
• Sleep: 2023 insomnia review found methodologically weak literature, few objective assessments [5]
• Safety: 2023 systematic review found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy [6]; NCCIH flags diarrhea, sleepiness, appetite changes, mood effects, liver abnormalities, drug interactions [1]
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrated in specific indications, not broad wellness claims [1]-[6]

CBG

• Evidence: Mostly review and preclinical; human evidence sparse [7][8]
• Pharmacology: Biosynthetic precursor, pharmacologically distinct from THC/CBD; interacts with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A signaling [7]
• Research areas: Possible relevance to neurologic disorders, inflammatory bowel disease, antibacterial activity — primarily pharmacology-led hypotheses/preclinical [7][8]
• Caution: 2021 review notes CBG sold commercially while evidence base remains thin, claims frequently outrun science [7]
• Bottom line: Serious research topic, but should be described as promising minor cannabinoid with limited clinical validation, not proven therapeutic [7][8]

Delta-8 THC

• Evidence: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11]
• Comparative pharmacology: 2022 review concluded similar pharmacokinetic/pharmacodynamic behavior to delta-9 THC; partial CB1 agonist, less potent likely due to weaker CB1 affinity [9]
• Public health: 2023 scoping review found evidence base dominated by animal studies, product chemistry, use reports, public health concerns rather than strong human trials; noted adverse consequences, emphasized regulatory/product-quality concerns [10]
• Manufacturing: 2024 review notes commercial interest tied to greater stability/easier synthesis relative to naturally scarce plant levels; product-byproduct and lab-testing questions matter [11]
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, more manufacturing-quality uncertainty than consumers realize [9]-[11]

THCa

• Evidence: Important chemically/formulation-wise, but low on direct human therapeutic evidence [12]
• What it is: Acidic precursor of THC; may represent large share of THC-related content in raw plant; decarboxylates to THC during heating and can change during storage/processing [12]
• Psychoactivity: THCa itself does not produce psychoactive effects, but distinction only holds if molecule stays acidic and isn’t substantially decarboxylated [12]
• Research status: In vitro/rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities; not equivalent to established human outcomes [12]
• Bottom line: Highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, storage; any claim must account for possible THC conversion [12]

Delta-9 THC

• Evidence: Strongest human evidence of psychoactive cannabinoids listed, but also clearest adverse-effect burden [1][13]-[15]
• Institutionally supported: NCCIH identifies THC-containing medicines relevant to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes; stresses many other uses uncertain/early-stage [1]
• Pain evidence: 2022 systematic review found high-THC or comparable THC:CBD products may provide short-term pain benefit but increased dizziness, sedation, nausea, treatment discontinuation [13]
• Pharmacokinetics: Inhaled THC: onset seconds-minutes, peaks ~15-30 minutes, tapers over few hours; oral THC: later onset, later peak, longer duration — matters for benefit and overconsumption risk [14]
• Mental health risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder; concerning signals for anxiety/depression in nontherapeutic settings [15]
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15]
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15]

CBN

• Evidence: Weak human evidence; marketing moved ahead of data [12][16][17]
• What marketed for: Sleep and sedation; reputation widespread but clinical support far thinner than market suggests [16][17]
• Sleep claim review: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or formal polysomnography to substantiate strong sleep-promoting claims [16]
• Broader sleep literature: 2024 updated review concluded cannabinoid sleep research still doesn’t match scale of real-world use; need for better-designed, adequately powered trials remains substantial [17]
• Chemical context: Review literature notes THC can degrade toward CBN under certain conditions, explaining why CBN discussed in aging/oxidized cannabis contexts [12]
• Bottom line: Clearest example where cultural reputation stronger than current clinical evidence base [16][17]

CBC

• Evidence: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19]
• Pharmacology: 2024 focused review argues distinct pharmacodynamics, pharmacokinetics, receptor behavior; highlights antinociceptive, antibacterial, anti-seizure as especially interesting research targets [18]
• Older literature: Review summarizing animal/in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance; not yet strong evidence for patient-facing claims [19]
• Safety caveat: 2024 CBC review explicitly notes over-the-counter CBC products sold despite little evidence establishing clinical efficacy or safety [18]
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19]

Terpene Profiles

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models rather than controlled human studies of cannabis formulations. 2024 entourage-effect review: terpene bioactivity plausible and sometimes compelling, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence: Largely review and preclinical, useful safety literature [20]-[22]
• Potential activity: 2021 review describes multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possible activities; overwhelming share from nonhuman/non-cannabis literature [21]
• Safety note: Limonene oxidation products, especially hydroperoxides, clinically relevant contact allergens in patch-testing literature [22]
• Bottom line: Biologically active, widely discussed, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans [20]-[22]

Myrcene

• Evidence: Mostly preclinical, very limited human evidence [20][23]
• Research summary: 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, discusses possible mechanisms; explicitly states human studies lacking [23]
• Interpretation caution: Myrcene often invoked in consumer language as proven sedating terpene explaining couch-lock/sleep effects; stronger claim than human evidence currently supports [20][23]
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, sedation remain far ahead of definitive human proof [23]

Caryophyllene

• Evidence: Among most mechanistically interesting due to direct cannabinoid-system relevance, but still mostly preclinical [24]
• Why it stands out: 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist, unusual, especially relevant when discussing cannabis terpenes pharmacologically rather than purely aromatically [24]
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions repeatedly discussed; human clinical confirmation limited [24]
• Bottom line: Arguably strongest candidate for terpene with cannabinoid-system significance, but still shouldn’t be described as clinically proven for outcomes commonly attributed [24]

Pinene

• Evidence: Promising preclinical literature, weak human clinical confirmation [20][25]
• Brain-health framing: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study; emphasized evidence mostly preclinical, well-designed clinical trials lacking [25]
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25]
• Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25]

Linalool

• Evidence: Similar to pinene: substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
• Research summary: Repeatedly discussed in relation to stress, mood, brain-health pharmacology; 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts while emphasizing lack of robust human trials [25]
• Additional literature: Separate review discusses possible antidepressant mechanisms, neuropharmacologic relevance; remains translational rather than definitive clinical story [26]
• Safety note: As with limonene, oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22]
• Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26]

Humulene

• Evidence: Translationally interesting, but early [20][27]
• Scoping-review findings: 2024 scoping review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects; some rodent work suggested cannabimimetic properties via CB1 and adenosine A2a pathways [27]
• Interpretation caution: Findings valuable for hypothesis generation, but don’t yet establish consistent human efficacy across pain, inflammation, mood outcomes [27]
• Bottom line: One of more interesting terpene research targets, but remains far from clinically settled [27]

Terpinolene

• Evidence: One of least clinically characterized terpenes in this file [20][28]
• Systematic-review findings: 2021 terpinolene review screened 2,449 records, included 57 studies, concluded range of reported biological effects but evidence base still dominated by in silico, in vitro, animal studies rather than human trials [28]
• Interpretation caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20]
• Bottom line: Biologically interesting, but among listed terpenes remains especially underdeveloped clinically [20][28]

Research Limits and Interpretation

• Evidence base highly uneven; CBD and delta-9 THC support most detailed human-facing statements; rest require more caution [1]-[29]
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, terpene-only data not interchangeable; common error is letting evidence from one category stand for another
• Minor cannabinoids and terpenes commercially interesting precisely because underexplored, but claims often become inflated
• Product quality matters as much as molecule identity: labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent pharmacokinetics all materially affect real-world interpretation [1][10][11][14]
• For THCa particularly, chemistry is destiny: storage and heating can change exposure profile by converting acidic cannabinoids to neutral forms like THC [12]

Common Overstatements to Avoid

• Overstatement: CBN is clinically proven sleep cannabinoid.
  More accurate: Specific sleep evidence for CBN remains weak and dated, no strong validated-trial base yet identified [16][17]
• Overstatement: Myrcene is proven human sedative that reliably explains couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for common claim is limited [20][23]
• Overstatement: Terpenes in general have proven entourage effects in patients.
  More accurate: Entourage hypotheses influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29]
• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself not THC, but heating/processing can convert THCa to THC, changing effective exposure [12]
• Overstatement: Delta-8 THC is safe because hemp-derived.
  More accurate: Delta-8 THC psychoactive, pharmacologically close to delta-9 THC, often entangled with manufacturing/testing concerns [9]-[11]

Practical Takeaways for Our Formulas

• Most evidence-developed actives: CBD and delta-9 THC
• Delta-8 THC not trivial or purely mild; psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC
• THCa meaningfully changes with processing; shouldn’t be interpreted same way in raw, gently handled, heated formats
• CBG, CBN, CBC scientifically credible but clinically immature compared to CBD/THC
• Listed terpenes likely highly relevant to aroma, flavor, potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported

RSO SUBLINGUAL OIL FORMULA

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle (1 fl oz)
• Active cannabinoids per mL: 553mg
• Carrier: Organic MCT oil
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Dosing: Graduated dropper in 0.1mL increments
• Price: $129.99

For Basotho: This is the complete formula. Every milligram is published. If you can source individual cannabinoid distillates, you can make this yourself. If you purchase from us, you get lab-tested, standardized product with full transparency.

RSO VAPE CARTRIDGE FORMULA

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1-gram cartridge
• Compatibility: 510-thread universal batteries
• Onset: 1-2 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Price: $49.99

For Basotho seeking fast relief: The vape format delivers cannabinoids in 1-2 minutes, ideal for breakthrough pain, acute nausea, or panic attacks. Every puff automatically decarboxylates THCa to delta-9 THC.

TERPENE PROFILE (BOTH PRODUCTS)

Our seven-terpene profile is identical across both formats:

• Limonene: Citrus-bright, uplifting aroma
• Myrcene: Earthy, musky base notes
• Caryophyllene (β-caryophyllene): Pepper/spice, CB2 receptor agonist
• Pinene: Forest-fresh, clarity-enhancing
• Linalool: Floral (lavender), calming
• Humulene: Earthy, woody, anti-inflammatory potential
• Terpinolene: Piney, fruity, sparkling complexity

For Basotho: These terpenes create a sensory experience that connects to familiar aromas — citrus fruits in your market, pine from Lesotho’s highland forests, lavender-like scents, pepper spices. The entourage effect literature [20][29] suggests these terpenes may complement cannabinoids, though robust human proof remains limited. What is certain is that they make the product experience more enjoyable and authentic.

FINAL WORDS FOR LESOTHO

Basotho have seen cannabis grow wild in your highlands for generations. You’ve watched Lesotho’s industrial hemp industry develop. You’ve heard whispers about RSO in cancer support groups in Maseru or among traditional healers in rural villages.

What we offer is different: transparency, evidence, and control.

• Transparency: We publish every milligram. No secrets. No proprietary blends.
• Evidence: We tell you exactly what the science says — and what it doesn’t.
• Control: You decide whether your medicine is psychoactive or not.

We cannot ship to Lesotho unless our products comply with your local laws. We cannot promise cures where science hasn’t proven them. We cannot replace your doctor’s advice.

What we can do:

• Provide the most advanced, multi-cannabinoid RSO formulation available
• Give you complete information to make informed decisions
• Offer a legal pathway to cannabis medicine through THCa chemistry
• Respect your intelligence and your right to choose

Contact us:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/

Age requirement: 21+ for all RSO products

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before use.

Legal notice: Buyer is responsible for verifying legality in their jurisdiction. Lesotho customers must confirm local hemp/cannabinoid regulations before ordering. We provide full documentation but accept no liability for customs seizures or legal issues. Void where prohibited by law.

Safety warning: May cause drowsiness or impairment. Do not operate vehicles or machinery under the influence. Keep out of reach of children. If pregnant or nursing, consult physician before use.

For the people of Lesotho: Whether you’re in the bustling streets of Maseru, the mountainous terrain of Mokhotlong, or the agricultural heartlands of Butha-Buthe, you deserve access to honest cannabis education and quality products. We hope this guide serves you well.

---